Key result
Routine investigation of prothrombotic risk factors in children with migraine is not recommended unless there is a family history of stroke or complicated migraine.
Answers are grounded in this paper and cite their sources.
Routine thrombophilia screening in children with migraine is unnecessary due to conflicting evidence and high costs, except in cases of complicated migraine or family history of stroke.
We read with great interest the recent article of Kutai et al (2011), which showed a high incidence of F5 A1691G and F2 G20210A in group of paediatric migraine patients in comparison with the control group from a population of Jewish population, and also increased factor VIII activity. The authors concluded that thrombophilia survey in migraine patients should be recommended, and there is some evidence that secondary haemostasis is altered either during or between migraine attacks, with a shift towards hypercoagulation. We recently analysed F5 A1691G and F2 G20210A mutations and factor (F)VIII, FIX, von Willebrand factor, antithrombin III, fibrinogen, homocysteine and lipoprotein A (lipA) levels in 28 children affected by migraine. We found no increased prothrombotic risk factor in our migraine patients when compared to controls with the exception of antithrombin III deficiency (Teber et al, 2007). Further, we studied antithrombin III levels in a larger population of 80 migraine patients, and we could not find any patient with low levels of antithrombin III (unpublished data). A further study investigated lipA levels in 63 migraine and 63 sex- and age-matched healthy controls; this study suggested that there is evidence of high lipA concentrations in migraine patients, however there was no significant difference between migraine with and without aura and no relationship between the levels of lipA levels and attack frequency and intensity were found (Teber et al, 2010). The role of lipA in migraine has been investigated only in a few studies. Cinzia et al (2009) determined plasma levels of lipA in 138 patients and 120 control subjects. They showed that abnormal lipA levels, which were defined as >300 mg/l, significantly influenced the predisposition to migraine after adjustment for age, sex, and vascular traditional risk factors. The results of studies regarding genetic factors related to thrombophilia are conflicting (D’Amico et al, 1998; Soriani et al, 1998; Intiso et al, 2002). Therefore, we believe that there is no need for the routine investigation of prothrombotic risk factors in children with migraine unless there is a family history of stroke or if the patient has complicated migraine, especially when taking account of the high cost of a whole thrombophilia survey.
No takes yet. Share an insight, caveat, or question.
Teber et al. (2011) conducted a letter in Childhood migraine. Prothrombotic risk factor screening was evaluated on Prothrombotic risk factors. Routine investigation of prothrombotic risk factors in children with migraine is not recommended unless there is a family history of stroke or complicated migraine.
Synapse has enriched 10 related papers. Consider them for comparative context: